Theratechnologies aims to improve the quality of life for HIV patients. Photograph: iStock

A Canadian speciality pharmaceutical company has appointed Dublin man Conor Walshe as general manager of its European subsidiary. Theratechnologies,(...)

Venn Life Sciences chief executive Tony Richardson. Venn has established full-service clinical research programmes and activities in 27 different countries

Clinical trials group Venn Life Sciences has signed a strategic collaboration with Open Orphan DAC as it seeks to increase its focus on rare diseases (...)

IPHA president GSK’s Aidan Lynch (centre); IPHA vice-president Paul Reid (Pfizer); and Bayer’s Itziar Canamasas with the Manifesto for Better Health ahead of the IPHA annual conference on November 8th. Photograph: Justin Mac Innes

Big Pharma in Ireland has an image problem. At least that’s how it sees it. “I think we are not seen as a trusted partner,” says Aidan Lynch, presid(...)

Venn Life Sciences chairman Allan Wood says that investment in business development should deliver an improved order book in future.

Shares in clinical trials group Venn Life Sciences fell to a new low after it reported a fall in sales and wider losses for the first six months of th(...)

Tony Richardson, Venn Life Sciences

Having assumed the role of chief executive of Venn Life Sciences in 2010, Tony Richardson quickly set about expanding the company, completing two acqu(...)

Venn Life Science provides clinical trials services to pharmaceutical and biotech companies.

Drug development firm Venn Life Sciences has raised £650,000 before expenses in a share sale. The company, which provides clinical trials services to(...)

Drug development firm Venn Life Sciences said it reported an overall loss of €1.5 million for last year as charges related to its investment in Dalkey(...)

Michael Carey, East Coast Bakehouse; Anne Heraty, CEO CPL Resources; and Kevin McLoughlin, partner lead for the EY EOY programme. Photograph: EY

The shortlist for the 2018 EY Entrepreneur of the Year (EOY) awards, now in its 21st year in Ireland, has been released with 24 finalists selected to (...)

Venn Life Sciences: the Irish company has refocused its strategy. Photograph: Vetta/Getty

The drug-development group Venn Life Sciences says its earnings have improved despite a fall in revenue. The Irish company, which is listed on the jun(...)

The company provides drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients

Revenue has continued to rise at Dublin-headquartered clinical trials group Venn Life Sciences with total income for the six months of the year up to (...)

  • 1
  • 2
  • 3
  • Next
  • Last »